Sun Pharma Advanced Research Company Limited - Company Profile

It is a pharma public limited company based in Manjusar, Gujarat, India, established in 2006.

2006 Manjusar, Gujarat, India Active

Last Updated: January 05, 2026

About Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited, a active public limited company, was established on 01 March 2006 in Manjusar, Gujarat, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: L73100GJ2006PLC047837. Registered under ROC Roc Ahmedabad. it is listed on BSE: 532872 and NSE: SPARC. It has an authorized capital of ₹42.50 Cr and a paid-up capital of ₹32.45 Cr.

It upholds a compliant status. In 2023, it reported revenue of ₹249.66 Cr and a net worth of ₹512.78 Cr. Employing 381 professional, Its leadership includes Dilip Shantilal Shanghvi (Director), Robert Jay Spiegel (Director), Rekha Gopal Warriar (Director). Past directors included Andrea Thaddaus Vasella, Sailesh Trambaklal Desai, Sudhir Vrundavandas Valia. It holds ₹545.00 Cr open charges and no settled loans. Its latest AGM occurred on 12 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli – Vadodara Highway,, Manjusar, Gujarat, 391775.

Company Details

CIN/LLPIN
L73100GJ2006PLC047837
Registration Number
047837
Incorporation Date
01 March 2006
Authorized Capital
₹42.50 Cr
Paid-Up Capital
₹32.45 Cr
ROC Code
Roc Ahmedabad
Listing Status
Listed (BSE: 532872, NSE: SPARC)
Company Status
Active

Key Metrics

Authorised Capital ₹ 42.50 Cr as on 05-01-2026
Paid Up Capital ₹ 32.45 Cr as on 05-01-2026
Company Age 20 Year, 2 Days
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 545.00 Cr as on 05-01-2026
Revenue Growth **** 73.26% (FY 2023)
Profit Growth **** -9.43% (FY 2023)
Ebitda **** -14.62% (FY 2023)
Net Worth 1542.20% (FY 2023)
Total Assets **** 196.39% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Sun Pharma Advanced Research Company Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sun Pharma Advanced Research Company Limited?

Current Directors

Name	Designation	Appointment Date	Status
Dilip Shantilal Shanghvi	Director	01 Mar 2006	Current
Robert Jay Spiegel	Director	01 Jun 2020	Current
Rekha Gopal Warriar	Director	19 May 2025	Current
Rajamannar Thennati	Director	04 Jun 2007	Current
Venkateswarlu Jasti	Director	19 May 2025	Current
Vidhi Dilip Shanghvi	Director	15 Jul 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	05 Aug 2017	Past
Pramod Abcsdd	Director	04 Jun 2007	Past
Pramod Abcsdd	Director	31 Jul 2014	Past
Pramod Abcsdd	Managing Director	25 May 2021	Past
Pramod Abcsdd	Director	05 Aug 2017	Past
Pramod Abcsdd	Additional Director	01 Aug 2015	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sun Pharma Advanced Research Company.

Sun Pharma Advanced Research Company Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 73.26% increase. The company also saw a slight decrease in profitability, with a 9.43% decrease in profit. The company's net worth Soared by an impressive increase of 1542.2%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

73.26%

*******

Revenue from Operations

*******

73.98%

*******

Total Assets

*******

196.39%

*******

Profit or Loss

*******

-9.43%

*******

Net Worth

*******

1542.20%

*******

EBITDA

*******

-14.62%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sun Pharma Advanced Research Company?

In 2023, Sun Pharma Advanced Research Company had a promoter holding of 65.67% and a public holding of 34.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹5,450,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Others : 545.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
17 Mar 2022	Others	₹145.00 Cr	Open
18 Feb 2021	Others	₹400.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Sun Pharma Advanced Research Company?

Sun Pharma Advanced Research Company has a workforce of 381 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sun Pharma Advanced Research Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharma Advanced Research Company's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sun Pharma Advanced Research Company

Recent Activity within the Organization

Charges

A charge with Others of Rs. 145.00 Cr registered on 17 Mar 2022 with Charge ID 100558353 was modified on 03 Dec 2025. was recorded as a recent event.
03 Dec 2025
Annual General Meeting

Progress on Sun Pharma Advanced Research Company Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records. was documented.
12 Aug 2025
Charges

The activity A charge with Others of Rs. 400.00 Cr registered on 18 Feb 2021 with Charge ID 100424977 was modified on 08 Jul 2025. was completed.
08 Jul 2025
Director Appointment

The activity Rekha Gopal Warriar was appointed as a Director was appointed as a Director on 19 May 2025 & has been associated with this company since 9 months 15 days . was completed.
19 May 2025
Director Appointment

The activity Venkateswarlu Jasti was appointed as a Director was appointed as a Director on 19 May 2025 & has been associated with this company since 9 months 15 days . was completed.
19 May 2025
Balance Sheet

Progress on Sun Pharma Advanced Research Company Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
31 Mar 2025

Explore recent activity and updates - View Recent Activity